Results 81 to 90 of about 29,825 (193)

Associations of finerenone with reduced insulin resistance in patients with type 2 diabetes and chronic kidney disease: A real‐world observational study

Journal of Diabetes Investigation, Volume 17, Issue 9, Page 1524-1532, September 2026.
This real‐world observational study enrolled 256 patients with type 2 diabetes and chronic kidney disease (T2D‐CKD). After 12 months of finerenone treatment, 45 patients completed follow‐up. Finerenone was associated with significant improvements in insulin resistance markers (HOMA‐IR, TyG index), lipid profile (LDL‐C), glycemic control (HbA1c), and ...
Xin Zhao, Bohan Liu, Ran Sun, Yaxuan Shi, Ya Liu   +4 more
wiley   +1 more source

Sodium zirconium cyclosilicate compared with potassium restriction for hyperkalemia management in type 2 diabetes: The SILVERSTAR trial

Journal of Diabetes Investigation, Volume 17, Issue 9, Page 1625-1633, September 2026.
ABSTRACT Aims/Introduction To demonstrate noninferiority of continued sodium zirconium cyclosilicate therapy versus a potassium‐restricted diet in achieving normokalemia at Visit 7 (Days 28–42) in individuals with type 2 diabetes and hyperkalemia, using a noninferiority margin of −10 percentage points (one‐sided α = 0.025).
Masahide Hamaguchi, Junya Hironaka, Hiroshi Okada, Mari Yoneda, Ayaka Kobayashi, Yoshitaka Hashimoto, Aya Kitae, Noriyuki Kitagawa, Akio Kishi, Michiyo Ishii, Mai Asano, Masahiro Yamazaki, Toru Tanaka, Hanako Nakajima, Eiko Sato, Michiaki Fukui   +15 more
wiley   +1 more source

Hyperkalemia and rhabdomyolyssis

Journal of Family Medicine and Primary Care, 2015
Sora Yasri, Viroj Wiwanitkit
openaire   +3 more sources

The Prevalence and Risk Factors of Hyperkalemia in the Outpatient Setting

International Journal of Nephrology
Background. Hyperkalemia is a life-threatening condition in outpatient and emergency departments. Hyperkalemia is associated with more events of major adverse cardiovascular diseases, hospitalization, and death.
Chadapa Sevamontree, Supreeya Jintajirapan, Pran Phakdeekitcharoen, Bunyong Phakdeekitcharoen   +3 more
doaj   +1 more source

The incidence of hyperkalemia in patients with secondary hyperparathyroidism after ultrasound-guided radiofrequency ablation vs. parathyroidectomy

Frontiers in Medicine
IntroductionThe aim of our study was to compare the incidence of hyperkalemia in maintenance dialysis patients with secondary hyperparathyroidism(SHPT) after parathyroidectomy(PTX) or ultrasound-guided radiofrequency ablation(RFA), and to explore the ...
Mian Ren, Yueming Liu, Bo Lin, Wenli Zou, Bin Zhu, Juan Wu   +5 more
doaj   +1 more source

Primidone Usage as a Rare Cause of Drug-Induced Hyperkalemia

Turkish Journal of Nephrology, 2019
Hyperkalemia is a life-threatening electrolyte disorder. Elderly patients are more prone to developing hyperkalemia due to age-related decline in glomerular fi ltration rate.
Mehmet BÜYÜKBAKKAL, Barış ESER, Özlem YAYAR, Zafer ERCAN, Aysun KUTLUGÜN, Hadim AKOĞLU, Bülent ERDOĞAN, Özgür MERHAMETSİZ, Mehmet Deniz AYLI   +8 more
doaj  

Incidence of hyperkalemia RAASi and SGLT-2i treatment in individuals with diabetic kidney disease: a systematic review and network meta-analysis

Frontiers in Pharmacology
BackgroundThis study aims to evaluate the incidence of hyperkalemia and serum potassium levels associated with the use of sodium-glucose cotransporter-2 inhibitors (SGLT-2i), renin‐angiotensin‐aldosterone system inhibitors (RAASi) and concurrent use of ...
Yahui Yuan, Yahui Yuan, Yahui Yuan, Chun Chen, Yuping Lin, Yehao Luo, Yehao Luo, Yehao Luo, Zhaojun Yang, Zhaojun Yang, Zhaojun Yang, Jingyi Guo, Jingyi Guo, Jingyi Guo, Qiaoyun Liu, Qiaoyun Liu, Qiaoyun Liu, Lu Sun, Guanjie Fan, Guanjie Fan, Guanjie Fan   +20 more
doaj   +1 more source

Abstracts from the 2026 Congress of the Scandinavian Society of Anesthesiology and Intensive Care Medicine, Reykjavik, Iceland, June 10–12, 2026

Acta Anaesthesiologica Scandinavica, Volume 70, Issue 9, October 2026.
wiley   +1 more source

A comparative study of the prevalence of hyperkalemia with the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers

Therapeutics and Clinical Risk Management, 2009
Seyed Ali Sadjadi1, James I McMillan1, Navin Jaipaul1, Patricia Blakely1, Su Su Hline21Section of Nephrology (111N), Jerry L Pettis Memorial Veterans Medical Center, Loma Linda, CA, USA; 2Divison of Nephrology, Loma Linda University Medical ...
Seyed Ali Sadjadi, James I McMillan, Navin Jaipaul, Patricia Blakely, et al.   +4 more
doaj  

Frequency, Management, and Outcomes of Outpatient Hyperkalemia: A Population-Based Cohort Study

Canadian Journal of Kidney Health and Disease
Background: Hyperkalemia is a potentially life-threatening condition, with guidelines recommending urgent treatment when the serum potassium level is greater than 6.0 mmol/L.
Michael Chiu, Nivethika Jeyakumar, Graham Smith, Danielle M. Nash, Mohamed Abou El Hassan, Dana Bailey, Peter Catomaris, Kika Veljkovic, Louise Moist, Amit X. Garg, Arsh K. Jain   +10 more
doaj   +1 more source